Back to M&G Plc M&G Plc

BRNSBRNS
10 quarters

Position history for M&G PlcM&G Plc's holdings in BARINTHUS BIOTHERAPEUTICS PL

M&G Plc holds 5.2M shares of BRNS (BARINTHUS BIOTHERAPEUTICS PL), worth $5.2M as of 2026-Q2. BRNS represents 0.0% of M&G Plc's portfolio.

Current Value

$5.2M

Current Shares

5.2M

Total Value Change

-$5.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.2M
0.0%
$5.2M0.0%$0.66
0
2026-Q1
Unchanged
5.2M
0.0%
$5.2M0.0%$0.60
0
2025-Q4
Unchanged
5.2M
0.0%
$5.2M0.0%$0.68
0
2025-Q3
Unchanged
5.2M
0.0%
$5.2M0.0%$1.48
0
2025-Q2
Unchanged
5.2M
0.0%
$5.2M0.0%$0.92
0
2025-Q1
Unchanged
5.2M
0.0%
$5.2M0.0%$1.05
0
2024-Q4
Unchanged
5.2M
0.0%
$5.2M0.0%$1.10
0
2024-Q3
Unchanged
5.2M
0.0%
$5.2M0.0%$1.18
0
2024-Q2
Unchanged
5.2M
0.0%
$5.2M0.0%$1.40
0
2024-Q1
New
5.2M
-
$10.4M0.0%$2.38
38

Other major holders of BRNS: TUDOR INVESTMENT CORP ET AL, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used